Session4

Tuesday, September 12th, 18:00h UTC // 20:00h CEST

Please click here to see your local time zone

Chair: Necmettin Unal, Turkey

 


Evidence Based Therapy – What Is New?
Simon Finfer, The George Institute for Global Health, Australia

The Impact of Governmental Regulations on Sepsis Outcomes in New York State
Mitchell Levy, Brown University, United States

Sepsis Quality Improvement Initiatives Save Lives
Vida Hamilton, Health Service Executive, Ireland

Enhancing Sepsis Survivorship
Hallie Prescott, University of Michigan, United States

The New Sepsis Definitions - Pros and Cons
Flavia Machado, Latin American Sepsis Institute, Brazil

The Potential of Biomarkers for Antibiotic Stewardship
Philipp Schuetz, Cantonal Hospital Aarau, Switzerland

Novel and Emerging Diagnostics
Michael Bauer, Jena University Hospital, Germany

Novel and Emerging Treatments
Richard Hotchkiss, Washington University, United States